51. Pyroptosis-Related Gene Signature Is a Novel Prognostic Biomarker for Sarcoma Patients
- Author
-
Qiang Tang, Liuzhi Wei, Xiaoling Lan, Yanfei Ma, Jingjie Zhao, Qiuju Wei, Siyuan He, Zhiqun Huang, Qianli Tang, Zechen Wang, Jian Song, Jiajia Shen, Lingzhang Meng, and Dalong Wei
- Subjects
Medicine (General) ,Article Subject ,Clinical Biochemistry ,Biology ,R5-920 ,Immune system ,Biomarkers, Tumor ,Pyroptosis ,Tumor Microenvironment ,Genetics ,medicine ,Humans ,Molecular Biology ,Gene ,Retrospective Studies ,Cell growth ,Proportional hazards model ,Biochemistry (medical) ,Mesenchymal stem cell ,Cancer ,Sarcoma ,General Medicine ,Prognosis ,medicine.disease ,Cancer research ,Research Article - Abstract
Sarcoma is a rare and an extremely aggressive form of cancer that originates from mesenchymal cells. Pyroptosis exerts a dual effect on tumours by inhibiting tumour cell proliferation while creating a microenvironment suitable for tumour cell development and proliferation. However, the significance of pyroptosis-related gene (PRG) expression in sarcoma has not yet been evaluated. Here, we conduct a retrospective analysis to examine PRG expression in 256 sarcoma samples from The Cancer Genome Atlas database. We identified the PRGs that had a significant correlation with overall patient survival in sarcoma by performing a univariate Cox regression analysis. Subsequently, we conducted a LASSO regression analysis and created a risk model for a six-PRG signature. As indicated from the Kaplan–Meier analysis, this signature revealed a significant difference between high- and low-risk sarcoma patients. A receiver operating characteristic curve analysis confirmed that this signature could predict overall patient survival in sarcoma patients with high sensitivity and specificity. Gene ontology annotation and Kyoto Encyclopaedia of Genes and Genomes pathway enrichment analyses revealed that five independent PRGs were closely associated with increased immune activity. Moreover, we also deciphered that increased number of immune cells infiltrated the tumour microenvironment in sarcoma. In brief, the PRG signature can effectively act as novel prognostic biomarker for sarcoma patients and is associated with the tumour immune microenvironment.
- Published
- 2021
- Full Text
- View/download PDF